UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Phase 1

Terminated

Conditions: Infiltrating Bladder Urothelial Carcinoma
Recurrent Bladder Carcinoma
Stage I Renal Cell Cancer
Stage II Bladder Urothelial Carcinoma
Stage IIB Prostate Cancer
Stage III Renal Cell Cancer
Stage I Prostate Cancer
Stage II Renal Cell Cancer
Stage IIA Prostate Cancer
Stage III Prostate Cancer

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis
Procedure: Radical Cystectomy
Biological: Recombinant EphB4-HSA Fusion Protein
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2016-05-11

Last Posted Date: 2021-11-24

Lead Sponsor: University of Southern California

Target Recruit Count: 2

Registration Number: NCT02767921

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Rehabilitation: Closed-Chain Exercises for Rotator Cuff Tears

Early Phase 1

Completed

Conditions: Full Thickness Rotator Cuff Tear

Interventions: Other: Closed chain exercises

First Posted Date: 2016-04-25

Last Posted Date: 2018-10-25

Lead Sponsor: University of Southern California

Target Recruit Count: 16

Registration Number: NCT02750176

Locations: 🇺🇸
Clinical Biomechanics Orthopedic and Sports Outcomes Research Laboratory, Los Angeles, California, United States

Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor

Withdrawn

Conditions: Gastrointestinal Stromal Tumor
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Premenopausal

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration
Procedure: Ultrasonography

First Posted Date: 2016-04-12

Last Posted Date: 2024-03-18

Lead Sponsor: University of Southern California

Registration Number: NCT02734823

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer

Terminated

Conditions: Stage III Bladder Cancer
No Evidence of Disease
Stage II Bladder Cancer
Stage IVA Bladder Cancer
Stage IVB Bladder Cancer

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis

First Posted Date: 2016-04-12

Last Posted Date: 2022-08-10

Lead Sponsor: University of Southern California

Target Recruit Count: 10

Registration Number: NCT02735512

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study

Not Applicable

Completed

Conditions: Aging
Cognitive Ability, General

Interventions: Behavioral: Moderate-aerobic walking
Radiation: Positron Emission Tomography (PET) scan
Behavioral: Healthy living education
Device: Physical activity monitor

First Posted Date: 2016-04-04

Last Posted Date: 2024-10-02

Lead Sponsor: University of Southern California

Target Recruit Count: 66

Registration Number: NCT02726906

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Memory Improvement Through Nicotine Dosing (MIND) Study

Phase 2

Active, not recruiting

Conditions: Mild Cognitive Impairment

Interventions: Drug: Nicotine Transdermal Patch
Drug: Placebo Patch

First Posted Date: 2016-03-25

Last Posted Date: 2024-12-27

Lead Sponsor: University of Southern California

Target Recruit Count: 380

Registration Number: NCT02720445

Locations: 🇺🇸
Perseverance Research Center, Scottsdale, Arizona, United States
🇺🇸
Central Arkansas Veterans Healthcare System, N. Little Rock, Arkansas, United States
🇺🇸
USC Rancho Los Amigos, Downey, California, United States

and more 32 locations

Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Phase 2

Recruiting

Conditions: Urothelial Carcinoma
Stage IV Bladder Urothelial Carcinoma
Prostate Cancer

Interventions: Procedure: Computed Tomography
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab
Procedure: Positron Emission Tomography
Biological: Recombinant EphB4-HSA Fusion Protein

First Posted Date: 2016-03-23

Last Posted Date: 2024-02-15

Lead Sponsor: University of Southern California

Target Recruit Count: 170

Registration Number: NCT02717156

Locations: 🇺🇸
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
USC Norris Oncology/Hematology - Newport Beach, Newport Beach, California, United States

and more 6 locations

Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients

Phase 1

Completed

Conditions: Recessive Dystrophic Epidermolysis Bullosa

Interventions: Drug: Placebo
Drug: Gentamicin

First Posted Date: 2016-03-04

Last Posted Date: 2019-10-29

Lead Sponsor: University of Southern California

Target Recruit Count: 5

Registration Number: NCT02698735

Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer

Not Applicable

Terminated

Conditions: Stage III Bladder Urothelial Carcinoma
Stage 0is Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma
Stage I Bladder Urothelial Carcinoma

Interventions: Other: Questionnaire Administration
Procedure: Radical Cystectomy

First Posted Date: 2016-03-04

Last Posted Date: 2019-05-03

Lead Sponsor: University of Southern California

Target Recruit Count: 1

Registration Number: NCT02699853

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Maternal GDM in Hispanic Youth: Risk for Obesity

Completed

Conditions: Insulin Resistance
Diabetes, Gestational
Obesity
Insulin Secretion

First Posted Date: 2016-01-29

Last Posted Date: 2019-04-16

Lead Sponsor: University of Southern California

Target Recruit Count: 240

Registration Number: NCT02668601

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy